| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,565 | 4,580 | 11:04 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| PAXMAN Aktie jetzt für 0€ handeln | |||||
| 07:00 | Paxman AB: PAXMAN publishes its interim report for Q1 2026 | 30 | GlobeNewswire (Europe) | Figures in parentheses refer to the outcome for the corresponding period of the previous year. Dignitana has been part of the group since June 1 2025.
The Group's sales amounted to 89.6 (67.1) MSEK... ► Artikel lesen | |
| 27.02. | Paxman AB: PAXMAN publishes year-end report as of 31 December 2025 | 1.173 | GlobeNewswire (Europe) | Strategic investments support future growth!
Figures in parentheses refer to the outcome for the corresponding period of the previous year.The Group's net sales amounted to 84.4 (66.2) MSEK for the... ► Artikel lesen | |
| 20.02. | Paxman AB: Paxman Announces Category III CPT Codes for Cryocompression Therapy to Prevent Chemotherapy-Induced Peripheral Neuropathy | 1.588 | GlobeNewswire (Europe) | Paxman, the global leader in cancer side effect management, today announced that the American Medical Association (AMA) CPT Editorial Panel has established three Category III CPT® codes describing the... ► Artikel lesen | |
| 14.11.25 | Paxman AB: PAXMAN publishes its interim report for Q3 2025 | 391 | GlobeNewswire (Europe) | First full post acquisition quarter builds momentum for 2026
(Dignitana has been part of the group since June 1. Figures in parentheses refer to the outcome for the corresponding period of the previous... ► Artikel lesen | |
| 20.08.25 | Paxman AB: PAXMAN publishes its interim report for Q2 2025 | 400 | GlobeNewswire (Europe) | Stronger Together: A New Era of Unity
Dignitana has been part of the group since June 1The Group's sales amounted to 74.9 (63.4) MSEK for the second quarter of the yearThe Group's net result totalled... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 58,58 | -0,02 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,660 | 0,00 % | Medicare Advantage Company Alignment Healthcare Shows Huge, Unusual Call Option Activity | ||
| BILLIONTOONE | 83,22 | -0,19 % | Jim Cramer on BillionToOne: "I Say Buy It" | ||
| PROGYNY | 25,660 | +0,08 % | Canaccord upgrades Progyny stock rating to buy on guidance beat streak | ||
| GENEDX | 44,740 | +0,02 % | GeneDx (WGS) Fell Despite Continued Execution Improvement | ||
| PROCEPT BIOROBOTICS | 28,090 | -0,07 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HEARTFLOW | 27,360 | -0,07 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 4,195 | -0,12 % | The Oncology Institute GAAP EPS of -$0.02 beats by $0.07, revenue of $147.4M beats by $5.42M | ||
| FRESENIUS | 40,370 | +0,50 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
15.05.2026 /... ► Artikel lesen | |
| GMR SOLUTIONS | 11,680 | 0,00 % | Nach Börsengang: GMR Solutions löst Vorzugsaktien ab und passt Corporate Governance an | ||
| AVEANNA HEALTHCARE | 7,680 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance | First Quarter Revenue was $647.9 million, a 15.9% increase over the prior year periodFirst Quarter Net income was $41.7 million compared to $5.2 million for the prior year periodAdjusted EBITDA for... ► Artikel lesen | |
| ALPHA TAU MEDICAL | 11,180 | 0,00 % | Alpha Tau Medical Ltd.: Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update | - Groundbreaking interim results from U.S. REGAIN trial in recurrent glioblastoma demonstrate 100% local disease control, 67% complete response rate, and favorable safety profile - - Completion of... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 8,610 | -0,12 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Initial Director's Interest Notice x 2 | ||
| CO-DIAGNOSTICS | 2,380 | -0,42 % | Co-Diagnostics Reports First Quarter 2026 Financial Results | Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion
Executing Clinical Strategy with Upper Respiratory Submission Preparation... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,680 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen |